An antibody that recognizes the protein FGFR4 delivers anticancer drugs directly to cancer cells.
October 2026. Full story at National Cancer Institute.
An antibody that recognizes the protein FGFR4 delivers anticancer drugs directly to cancer cells.
October 2026. Full story at National Cancer Institute.